Canton Strategic Holdings (CNTN) Notes Payables (2020 - 2025)

Canton Strategic Holdings (CNTN) posted Notes Payables of $161117.0 for Q3 2025, down 35.48% on a QoQ basis from $249716.0 in Q2 2025.

Canton Strategic Holdings (CNTN) Notes Payables (2020 - 2025) Analysis & Trends

Canton Strategic Holdings' Notes Payables history runs 3 years deep, the most recent figure standing at $161117.0 for Q3 2025.

Quarterly Notes Payables changed N/A year-over-year to $161117.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $161117.0 (changed N/A YoY) and the FY2021 annual result came in at $1.4 million, up 147.16% from the prior year.
Notes Payables was $161117.0 for Q3 2025 at Canton Strategic Holdings, down from $249716.0 in the prior quarter.
Across five years, Notes Payables topped out at $1.4 million in Q4 2021 and bottomed at $161117.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	66,621.14 Bn	66,620.85 Bn	-
2	Nanobiotix	1,915.18 Bn	1,915.11 Bn	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-
4	BeOne Medicines	471.27 Bn	466.48 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.81 Bn	114.57 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	69.58 Bn	60.82 Bn	3.31 Bn
7	Belite Bio	62.72 Bn	62.72 Bn	-
8	Argenx Se	55.51 Bn	50.33 Bn	1.41 Bn
9	Revolution Medicines	37.35 Bn	37.35 Bn	-
10	Canton Strategic Holdings	425.80 Mn	425.80 Mn	-

Download Data